Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer

Clinical trial NCT06736379 · RECRUITING

Trial details

NCT number: NCT06736379
Sponsor: VLP Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Cancers- Squamous Cell Head and Neck Cancer Solid Tumors HNSCC SCC - Squamous Cell Carcinoma SCCHN Head Neck Cancer Head and Neck Squamous Cell Cancer Squamous Cell Carcinoma of the Head and Neck Squamous Cell Carcinoma, Head And Neck Squamous Cell Head and Neck Carcinoma Oral Cavity

Start date: 2025-05-13
Primary completion: 2027-12-30
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.